FNA Paragon 28
- 7.460
- -0.230-2.99%
Paragon 28 News
Express News | NYSE Order Imbalance 53210.0 Shares on Buy Side
Form 144 | Paragon 28(FNA.US) Officer Proposes to Sell 1.73 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 30, $Paragon 28(FNA.US)$ Officer Deitsch Stephen intends to sell 221.98K shares of its common stock on May 30, with a total market value of approximately $1.73 million. D
Form 144 | Paragon 28(FNA.US) Officer Proposes to Sell 1.76 Million in Common Stocks
SEC FILLINGS DISCLOSED/ May 28, $Paragon 28(FNA.US)$ Officer Deitsch Stephen intends to sell 225K shares of its common stock on May 28, with a total market value of approximately $1.76 million. Sou
Earnings Call Summary | Paragon 28(FNA.US) Q1 2024 Earnings Conference
The following is a summary of the Paragon 28, Inc. (FNA) Q1 2024 Earnings Call Transcript:Financial Performance:Paragon 28 globally achieved a Q1 2024 revenue of $61.1 million, an increase of 17.4%.US
Paragon 28 Inc (FNA) Q1 2024 Earnings: Aligns With Revenue Projections and Reaffirms Full-Year ...
J.P. Morgan Securities: Maintaining the Paragon 28 (FNA.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $23.00 to $20.00.
J.P. Morgan Securities: Maintaining the Paragon 28 (FNA.US) rating, adjusted from better than market to better than market rating, and adjusted the target price from $23.00 to $20.00.
JMP Securities Maintains Market Outperform on Paragon 28, Lowers Price Target to $20
JMP Securities analyst David Turkaly maintains Paragon 28 (NYSE:FNA) with a Market Outperform and lowers the price target from $23 to $20.
Paragon 28 Price Target Cut to $15.00/Share From $18.00 by Piper Sandler
Paragon 28 Price Target Cut to $15.00/Share From $18.00 by Piper Sandler
Q1 2024 Paragon 28 Inc Earnings Call
Paragon 28: A Robust Growth Trajectory With a Bright Future – Buy Recommendation
Paragon 28 (FNA) Gets a Buy From Piper Sandler
Paragon 28 Is Maintained at Buy by Needham
Paragon 28 Is Maintained at Buy by Needham
Needham: Maintains Paragon 28 (FNA.US) rating, adjusted from buy to buy rating, and adjusted target price from $17.00 to $14.00.
Needham: Maintains Paragon 28 (FNA.US) rating, adjusted from buy to buy rating, and adjusted target price from $17.00 to $14.00.
Needham Maintains Buy on Paragon 28, Lowers Price Target to $14
Needham analyst Mike Matson maintains Paragon 28 with a Buy and lowers the price target from $17 to $14.
Paragon 28 Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 05/09/2024 69.49% Needham $17 → $14 Maintains Buy 04/05/2024 117.92% Stephens & Co. → $18 Reiterates Overw
Analysts Offer Insights on Healthcare Companies: Teva Pharmaceutical (TEVA), Zentalis Pharmaceuticals (ZNTL) and Paragon 28 (FNA)
Paragon 28's Sustained Growth and Strategic Initiatives Bolster Buy Rating
Analysts Are Bullish on These Healthcare Stocks: Paragon 28 (FNA), Prothena (PRTA)
Paragon 28 Reports Q1 Results
Paragon 28 | 10-Q: Quarterly report
Analysis
Price Target
No Data
